These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 7194097)
1. Characterization of a new potent heparin. 6th communication: The comparison of the anticoagulant effect of the sodium and calcium salts of a new potent heparin after s.c. injection in beagle dogs. Bhargava AS; Schöbel C; Günzel P Arzneimittelforschung; 1981; 31(1):79-82. PubMed ID: 7194097 [TBL] [Abstract][Full Text] [Related]
2. Characterization of a new potent heparin. 1 communication: Determinations of anticoagulant activity of a high potency heparin preparation in vivo using dog as an experimental animal and in vitro using dog and human plasma. Bhargava AS; Heinick J; Schöbel C; Günzel P Arzneimittelforschung; 1980; 30(6):993-6. PubMed ID: 7191280 [TBL] [Abstract][Full Text] [Related]
3. Characterization of a new potent heparin. 7th communication: A comparative study of a new potent heparin in human after i.v. application. Bhargava AS; Wendt H; Günzel P Arzneimittelforschung; 1981; 31(2):386-8. PubMed ID: 7194658 [TBL] [Abstract][Full Text] [Related]
4. [Comparative evaluation of the anticoagulant activity of the sodium and calcium salts of heparin, isolated from swine intestinal mucosa]. Ushkalova EA; Kremneva VF; Ovchinnikova LK; Shcheglova NV Farmakol Toksikol; 1989; 52(3):51-5. PubMed ID: 2792354 [TBL] [Abstract][Full Text] [Related]
5. Characterization of a new potent heparin. 3rd Communication: Determinations of anticoagulant activity of a new potent heparin preparation by thrombelastography in vitro using citrated dog and human blood. Bhargava AS; Freihube G; Günzel P Arzneimittelforschung; 1980; 30(8):1256-8. PubMed ID: 7192139 [TBL] [Abstract][Full Text] [Related]
6. A comparison of pentosan polysulphate and heparin. II: Effects of subcutaneous injection. Fischer AM; Merton RE; Marsh NA; Williams S; Gaffney PJ; Barrowcliffe TW; Thomas DP Thromb Haemost; 1982 Apr; 47(2):109-13. PubMed ID: 6179183 [TBL] [Abstract][Full Text] [Related]
7. [Heparin level and coagulation potential after subcutaneous injection of 7500 international units of heparin calcium]. Briel RC Dtsch Med Wochenschr; 1984 Jun; 109(25):993-6. PubMed ID: 6734457 [TBL] [Abstract][Full Text] [Related]
8. Activated coagulation time in monitoring heparinized dogs. Green RA Am J Vet Res; 1980 Nov; 41(11):1793-7. PubMed ID: 7212408 [TBL] [Abstract][Full Text] [Related]
9. Characterization of a new potent heparin. 2nd communication: Chemical analysis of the carbohydrate content and determination of the biological activity of a new potent heparin preparation in vitro, using protamine neutralization and amidolytic methods for factor Xa and thrombin. Bhargava AS; Heinick J; Günzel P Arzneimittelforschung; 1980; 30(7):1071-4. PubMed ID: 7191289 [TBL] [Abstract][Full Text] [Related]
10. Characterization of a new potent heparin. 4th communication: The effect of a new potent heparin preparation on lipid components and leucocytes in rats after subcutaneous application. Bhargava AS; Staben P; Schöbel C; Günzel P Arzneimittelforschung; 1980; 30(9):1562-6. PubMed ID: 7193025 [TBL] [Abstract][Full Text] [Related]
11. Activated partial thromboplastin time and activated coagulation time in monitoring heparinized cats. Greene CE; Meriwether E Am J Vet Res; 1982 Aug; 43(8):1473-7. PubMed ID: 7103231 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of low-molecular-weight and unfractioned heparin in horses. Monreal L; Villatoro AJ; Monreal M; Espada Y; Anglés AM; Ruiz-Gopegui R Am J Vet Res; 1995 Oct; 56(10):1281-5. PubMed ID: 8928943 [TBL] [Abstract][Full Text] [Related]
13. The significance of TFPI in clotting assays--comparison and combination with other anticoagulants. Nordfang O; Kristensen HI; Valentin S; Ostergaard P; Wadt J Thromb Haemost; 1993 Sep; 70(3):448-53. PubMed ID: 8259547 [TBL] [Abstract][Full Text] [Related]
14. Preparation and anticoagulation activity of sodium cellulose sulfate. Wang ZM; Li L; Zheng BS; Normakhamatov N; Guo SY Int J Biol Macromol; 2007 Oct; 41(4):376-82. PubMed ID: 17602735 [TBL] [Abstract][Full Text] [Related]
15. Comparison of low molecular weight heparins and unfractionated heparin after successive subcutaneous administration. A randomized controlled study in healthy volunteers. Pindur G; Heiden M; Köhler M Arzneimittelforschung; 1993 May; 43(5):542-7. PubMed ID: 8392345 [TBL] [Abstract][Full Text] [Related]
16. A new route of heparin administration--the lung. Kavanagh LW; Jaques LB Arzneimittelforschung; 1976; 26(3):389-92. PubMed ID: 989334 [TBL] [Abstract][Full Text] [Related]
17. Comparison of a low-molecular-weight heparin (nadroparin calcium) and unfractionated heparin as adjunct to coronary thrombolysis with alteplase and aspirin in dogs. Jun L; Arnout J; Vanhove P; Dol F; Lormeau JC; Herbert JM; Collen D; Van de Werf F Coron Artery Dis; 1995 Mar; 6(3):257-63. PubMed ID: 7788040 [TBL] [Abstract][Full Text] [Related]
19. The anticoagulant and hemorrhagic effects of DHG, a new depolymerized holothurian glycosaminoglycan, on experimental hemodialysis in dogs. Minamiguchi K; Kitazato KT; Sasaki E; Nagase H; Kitazato K Thromb Haemost; 1997 Jun; 77(6):1148-53. PubMed ID: 9241748 [TBL] [Abstract][Full Text] [Related]
20. Use of hexadimethrine bromide as a heparin-neutralizing agent in canine plasma. Green RA; LaFollette KA; Greig B Am J Vet Res; 1987 Mar; 48(3):496-8. PubMed ID: 3565907 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]